UPDATE : Tuesday, October 15, 2019
Samsung Bioepis gets additional approval for its biosimilar by Lee Hye-seon 2017-09-21 12:03
MSD dissolves promotion team for Samsung Bioepis’ biosimilars by Lee Han-soo 2017-09-21 11:58
Sillajen emerges as biggest beneficiary of preferential listing by Nam Doo-hyun 2017-09-20 17:22
Samsung Bioepis gets nods for phase 3 trials to treat macular degeneration by Lee Han-soo 2017-09-19 17:39
Korean biopharmaceutical industry ranked 2nd among emerging countries by Marian Chu 2017-09-19 10:37
EU approvals for Samsung Bioepis push up share prices by Nam Doo-hyun 2017-09-18 14:45
Genexin, Handok presents persistent growth hormone clinical trial results by Lee Han-soo 2017-09-18 14:39
Celltrion in controversy over sexual harassment case by Lee Han-soo 2017-09-15 18:11
‘Knowledge’ is core ability for bio industrialists, survey says by Nam Doo-hyun 2017-09-15 16:28
Access Bio, PFSCM sign supply agreement for malaria kit by Lee Han-soo 2017-09-15 14:52
‘BIOplus Incheon 2017’ shares product-developing know-how by Lee Han-soo 2017-09-14 11:14
Medipost to commercialize new stem cell-culture tech by Constance Williams 2017-09-14 10:38
Hanall Biopharma made $81-million technology export to China by Lee Hye-seon 2017-09-13 13:23
New VC investments in bio, medical fields fall sharpest in H1 by Nam Doo-hyun 2017-09-13 13:23
Celltrion presents Herzuma’s clinical results in Europe by Lee Han-soo 2017-09-11 12:19
Kang Stem, Heraeus Medical to develop anti-arthritis drug by Lee Han-soo 2017-09-08 15:25
Pharma Research Product releases home care cosmetics by Lee Han-soo 2017-09-07 17:08
Cellivery gets research funding from US Foundation by Lee Han-soo 2017-09-07 15:00
Abclon confirms IPO at 10,000 won per share by Lee Han-soo 2017-09-07 11:48
Papers related to stem cell therapy rising worldwide by Nam Doo-hyun 2017-09-06 16:45
Back to Top